Important notice regarding Rhopressa

Posted in Latest News on February 12, 2019.

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.



More Latest News

Important Information on Fraudulent Emails to Practitioners
August 1, 2023

The Department of Health, Division of Medical Quality Assurance, is warning Florida health care practitioners about fraudulent emails that have been received by multiple licensees. Continue reading →


New Legislation Impacting Your Profession
June 28, 2023

Click here to view a full list of bill summaries from the 2023 Florida Legislative Session that may impact your profession. Continue reading →